European Journal of Internal Medicine
Volume 19, Issue 7 , Pages 516-519 , November 2008

Occult nasal sinus tumours causing oncogenic osteomalacia

  • Helen Kenealy

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Respiratory Medicine, Auckland City Hospital, Park Road, Grafton, Auckland 1023, New Zealand. Tel.: +64 9 3760000; fax: +64 9 6310770.
    • ,
  • Ian Holdaway
    • ,
  • Andrew Grey

Received 9 November 2007 ,Accepted 20 January 2008.

References 

  1. Folpe AL, Fanburg-Smith JC, Billings SD, et al. An analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol. 2004;28:1–30
  2. Drezner MK. Table 1 Tumour-Induced Osteomalcia in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 4th Edition Chapter 65. Pages 332--333. Ed Murray J Favus. Lipincott Williams and Wilkins Philadelphia, 1999.
  3. Dissanayake AM, Wilson JL, Holdaway IM, Reid IR. Oncogenic osteomalacia: culprit tumour detection whole body magnetic resonance imaging. Intern Med J. 2003;33:615616
  4. Palacios E, Restrepo S, Mastrogiovanni L, Lorusso GD, Rojas R. Sinonasal haemangiopericytomas: clinicopathologiac and imaging findings. Ear Nose Throat J. 2005;84:99–102
  5. Fukumoto S, Takeuchi Y, Nagano A, Fujita T. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia. Bone. 1999;25:375–377
  6. Sundaram M, McCarthy EF. Oncogenic osteomalacia. Review article. Skeletal Radiol. 2000;29:117–124
  7. Jan de Beur SM, Streeten EA, Civelek AC, et al. Localisation of mesenchymal tumours by somatostatin receptor imaging. Lancet. 2002;359:761–763
  8. Rhee Y, Lee JD, Shin KH, Lee HC, Huh KP, Lim SK. Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy. Clin Endocrinol. 2001;54:551–555
  9. Suefert J, Ebert K, Mueller J, et al. Octreotide therapy for tumour-induced osteomalacia. N Eng J Med. 2001;345:1883–1888
  10. Nelson AE, Clifton Bligh R, Mirams M, et al. Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia. Clinical case seminar. J Clin Endocrinol Metab. 2003;88:4088–4094
  11. Jan de Beur SM. Tumor-induced osteomalacia. JAMA. 2005;294:1260–1267
  12. Quarles L Darryl. Evidence for a bone–kidney axis regulating phosphate homeostasis. J Clin Invest. 2003;112:642–646

PII: S0953-6205(08)00052-6

doi: 10.1016/j.ejim.2008.01.011

European Journal of Internal Medicine
Volume 19, Issue 7 , Pages 516-519 , November 2008

Article Tools

* Image Usage & Resolution